Low density lipoprotein: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) |
Rim Halaby (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{Low density lipoprotein}} | ||
{{CMG}}; {{AE}} {{CZ}}; {{Rim}} | {{CMG}}; {{AE}} {{CZ}}; {{Rim}} | ||
{{SK}} | {{SK}} Low density lipoprotein-cholesterol, Low density lipoprotein-C | ||
== | == [[Low density lipoprotein overview|Overview]] == | ||
== [[Low density lipoprotein historical perspective|Historical Perspective]] == | |||
== [[Low density lipoprotein classification|Classification]] == | |||
== [[Low density lipoprotein biochemistry|Biochemistry]] == | |||
== [[Low density lipoprotein physiology|Physiology]] == | |||
== Clinical Correlation== | |||
===[[High LDL]]=== | |||
[[High LDL epidemiology and demographics|Epidemiology and Demographics]] | [[High LDL pathophysiology|Pathophysiology]] | [[High LDL causes|Causes]] | [[High LDL diseases|Diseases]] | [[High LDL prognosis and complications|Prognosis and Complications]] | |||
===[[Low LDL]]=== | |||
[[Low LDL epidemiology and demographics|Epidemiology and Demographics]] | [[Low LDL pathophysiology|Pathophysiology]] | [[Low LDL causes|Causes]] | [[Low LDL diseases|Diseases]] | [[Low LDL prognosis and complications|Prognosis and Complications]] | |||
== Treatment == | |||
[[Low density lipoprotein medical therapy|Medical Therapy]] | [[Low density lipoprotein primary prevention|Primary Prevention]] | [[Low density lipoprotein secondary prevention|Secondary Prevention]] | [[Low density lipoprotein landmark trials|Landmark Trials]] | [[Low density lipoprotein future or investigational therapies|Future or Investigational Therapies]] | |||
{{Lipoproteins}} | {{Lipoproteins}} | ||
Revision as of 17:46, 12 September 2013
Template:Low density lipoprotein Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Rim Halaby, M.D. [3]
Synonyms and keywords: Low density lipoprotein-cholesterol, Low density lipoprotein-C
Overview
Historical Perspective
Classification
Biochemistry
Physiology
Clinical Correlation
High LDL
Epidemiology and Demographics | Pathophysiology | Causes | Diseases | Prognosis and Complications
Low LDL
Epidemiology and Demographics | Pathophysiology | Causes | Diseases | Prognosis and Complications
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Landmark Trials | Future or Investigational Therapies